SCHEMBL20168301

SCHEMBL20168301

C=CCC[C@H](Cc1ccc(C(=O)OC(C)C)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.44
CYP4A11 Q02928 1/20 0.44
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA7 P43166 2/20 0.40
CA9 Q16790 2/20 0.40
CA14 Q9ULX7 2/20 0.40
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
CACNA1B Q00975 5/20 0.35
THRA P10827 1/20 0.34
THRB P10828 1/20 0.34
NPC1 O15118 3/20 0.34
ALDH1A1 P00352 3/20 0.34
RAB9A P51151 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
LMNA P02545 2/20 0.34
HTT P42858 1/20 0.34
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20179181 1.00 CYP4F2 (0.44) CYP4F2CYP4A11CA12CA1CA2
SCHEMBL20179138 0.91 SLC7A5 (0.38) CA12CA1CA2CA9CA14
SCHEMBL20168666 0.91 SLC7A5 (0.38) CA12CA1CA2CA9CA14
SCHEMBL20168531 0.87 CA12 (0.40) CA12CA1CA2CA7CA9
SCHEMBL20179148 0.87 CA12 (0.40) CA12CA1CA2CA7CA9
SCHEMBL20179182 0.87 CYP4F2 (0.47) CYP4F2CYP4A11CA12CA1CA2
SCHEMBL20168576 0.87 CYP4F2 (0.47) CYP4F2CYP4A11CA12CA1CA2
SCHEMBL21578144 0.86 CYP4F2 (0.48) CYP4F2CYP4A11CA12CA1CA2
SCHEMBL20168303 0.84 CYP4F2 (0.49) CYP4F2CYP4A11CA12CA1CA2
SCHEMBL20168716 0.84 CYP4F2 (0.46) CYP4F2CYP4A11CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094334-A1 PRODRUGS OF HYDROXAMATE-BASED GCPII INHIBITORS THE JOHNS HOPKINS UNIVERSITY (US) 2018-05-24 WO disclosed